Advertisement

Carfilzomib Plus Dexamethasone in Previously Treated Multiple Myeloma

On January 21, 2016, carfilzomib (Kyprolis) was approved for use in combination with dexamethasone in patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.

 The ASCO Post